Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgPro20 as Infection Prophylaxis in MM Patients Receiving BsAbs
NCT06976476Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2025
- Primary completion
- May 2029
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of immune serum globulin in hypogammaglobulinemia, sponsored by Memorial Sloan Kettering Cancer Center. Started May 2025; status: recruiting.
02
Drugs
immune serum globulin
03
Conditions
hypogammaglobulinemia
Beyond the preview
Go deeper on NCT06976476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06976476.